Hartmut Jaeschke

Author PubWeight™ 138.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol 2012 3.15
2 Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013 3.00
3 Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 2004 2.92
4 The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 2012 2.65
5 Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 2002 2.42
6 Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J Pharmacol Exp Ther 2005 2.41
7 Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology 2011 2.15
8 Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology 2010 2.15
9 Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol Sci 2004 2.07
10 Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 2003 2.00
11 Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007 1.99
12 Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. Toxicol Sci 2006 1.94
13 Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol 2010 1.91
14 Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Am J Pathol 2009 1.87
15 HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology 2011 1.86
16 c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2010 1.84
17 Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther 2002 1.73
18 Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology 2013 1.71
19 Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity. J Pharmacol Exp Ther 2007 1.70
20 A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 2007 1.70
21 Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 2013 1.62
22 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2006 1.54
23 Mechanisms of immune-mediated liver injury. Toxicol Sci 2010 1.48
24 Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicol Appl Pharmacol 2013 1.46
25 Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radic Res 2010 1.45
26 Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol 2012 1.45
27 Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 2013 1.41
28 Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. Am J Physiol Gastrointest Liver Physiol 2003 1.40
29 Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol Sci 2012 1.38
30 Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury. Toxicol Appl Pharmacol 2010 1.38
31 Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2006 1.37
32 Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int 2011 1.34
33 Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury. Hepatology 2008 1.31
34 Novel insight into mechanisms of cholestatic liver injury. World J Gastroenterol 2012 1.31
35 Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. Am J Pathol 2006 1.30
36 Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient mice. Liver Int 2010 1.29
37 Parkin and mitofusins reciprocally regulate mitophagy and mitochondrial spheroid formation. J Biol Chem 2012 1.25
38 Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice. J Pharmacol Exp Ther 2003 1.25
39 NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia. Am J Physiol Gastrointest Liver Physiol 2004 1.23
40 The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2011 1.23
41 Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic preconditioning. Am J Physiol Gastrointest Liver Physiol 2005 1.22
42 Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis 2010 1.22
43 Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury. Toxicol Appl Pharmacol 2011 1.21
44 Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol Sci 2011 1.16
45 Serum glutamate dehydrogenase--biomarker for liver cell death or mitochondrial dysfunction? Toxicol Sci 2013 1.15
46 Lysosomal iron mobilization and induction of the mitochondrial permeability transition in acetaminophen-induced toxicity to mouse hepatocytes. Toxicol Sci 2010 1.15
47 Pathophysiological relevance of neutrophils in acetaminophen hepatotoxicity. Hepatology 2013 1.14
48 Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 2004 1.13
49 Plasminogen activator inhibitor-1 limits liver injury and facilitates regeneration after acetaminophen overdose. Toxicol Sci 2008 1.11
50 Acetaminophen toxicity in mice lacking NADPH oxidase activity: role of peroxynitrite formation and mitochondrial oxidant stress. Free Radic Res 2003 1.10
51 Role of lipid peroxidation as a mechanism of liver injury after acetaminophen overdose in mice. Toxicol Sci 2003 1.09
52 Role of heme oxygenase 1 in TNF/TNF receptor-mediated apoptosis after hepatic ischemia/reperfusion in rats. Shock 39: 380-388, 2013. Shock 2013 1.09
53 Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice. Toxicol Appl Pharmacol 2013 1.08
54 Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch Toxicol 2013 1.08
55 Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology 2014 1.07
56 Purinergic receptor antagonist A438079 protects against acetaminophen-induced liver injury by inhibiting p450 isoenzymes, not by inflammasome activation. Toxicol Sci 2012 1.05
57 The oxygen tension modulates acetaminophen-induced mitochondrial oxidant stress and cell injury in cultured hepatocytes. Toxicol Sci 2010 1.05
58 Oxidant stress-induced liver injury in vivo: role of apoptosis, oncotic necrosis, and c-Jun NH2-terminal kinase activation. Am J Physiol Gastrointest Liver Physiol 2009 1.02
59 Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients. Expert Opin Drug Metab Toxicol 2014 1.02
60 Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion. Toxicol Appl Pharmacol 2002 1.02
61 Inflammation in response to hepatocellular apoptosis. Hepatology 2002 1.01
62 Mechanism of protection by metallothionein against acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2009 1.00
63 Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury. Toxicol Mech Methods 2007 0.98
64 Innate immunity and acetaminophen-induced liver injury: why so many controversies? Hepatology 2008 0.98
65 Zonated induction of autophagy and mitochondrial spheroids limits acetaminophen-induced necrosis in the liver. Redox Biol 2013 0.97
66 Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice. Liver Transpl 2014 0.96
67 No evidence for caspase-dependent apoptosis in acetaminophen hepatotoxicity. Hepatology 2010 0.95
68 The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation. Toxicol Appl Pharmacol 2013 0.95
69 Neutrophil depletion protects against murine acetaminophen hepatotoxicity: another perspective. Hepatology 2007 0.95
70 Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice. Am J Physiol Gastrointest Liver Physiol 2007 0.94
71 Generation and functional significance of CXC chemokines for neutrophil-induced liver injury during endotoxemia. Am J Physiol Gastrointest Liver Physiol 2004 0.94
72 The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Lab Invest 2010 0.94
73 Mouse strain-dependent caspase activation during acetaminophen hepatotoxicity does not result in apoptosis or modulation of inflammation. Toxicol Appl Pharmacol 2011 0.94
74 Mitochondrial protein thiol modifications in acetaminophen hepatotoxicity: effect on HMG-CoA synthase. Toxicol Lett 2008 0.93
75 Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium. Liver Int 2009 0.93
76 The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis. Am J Pathol 2009 0.92
77 Recovery of hepatocellular ATP and "pericentral apoptosis" after hemorrhage and resuscitation. FASEB J 2003 0.91
78 Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. Toxicol Sci 2013 0.91
79 Oncotic necrosis and caspase-dependent apoptosis during galactosamine-induced liver injury in rats. Toxicol Appl Pharmacol 2003 0.91
80 Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice. Toxicol Lett 2013 0.89
81 Heme oxygenase-1 induction in hepatocytes and non-parenchymal cells protects against liver injury during endotoxemia. Comp Hepatol 2004 0.88
82 The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers. Hepatology 2009 0.86
83 Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers 2014 0.86
84 Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice. Toxicol Sci 2004 0.85
85 Fas receptor-deficient lpr mice are protected against acetaminophen hepatotoxicity due to higher glutathione synthesis and enhanced detoxification of oxidant stress. Food Chem Toxicol 2013 0.85
86 Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice. J Pharmacol Exp Ther 2012 0.84
87 Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice. Toxicol Appl Pharmacol 2010 0.83
88 Reactive oxygen as modulator of TNF and fas receptor-mediated apoptosis in vivo: studies with glutathione peroxidase-deficient mice. Antioxid Redox Signal 2002 0.83
89 Time course of acetaminophen-protein adducts and acetaminophen metabolites in circulation of overdose patients and in HepaRG cells. Xenobiotica 2015 0.83
90 How relevant are neutrophils for acetaminophen hepatotoxicity? Hepatology 2006 0.83
91 Mechanisms and pathophysiological implications of sinusoidal endothelial cell gap formation following treatment with galactosamine/endotoxin in mice. Am J Physiol Gastrointest Liver Physiol 2006 0.82
92 Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress. Drug Metab Dispos 2007 0.82
93 Herbal extracts as hepatoprotectants against acetaminophen hepatotoxicity. World J Gastroenterol 2010 0.82
94 Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity. Basic Clin Pharmacol Toxicol 2012 0.81
95 Regulation of apoptotic signaling pathways in hepatocytes in vivo. Hepatology 2003 0.81
96 Chlorotyrosine protein adducts are reliable biomarkers of neutrophil-induced cytotoxicity in vivo. Comp Hepatol 2004 0.81
97 Peroxynitrite formation and sinusoidal endothelial cell injury during acetaminophen-induced hepatotoxicity in mice. Comp Hepatol 2004 0.79
98 Caveats of using acetaminophen hepatotoxicity models for natural product testing. Toxicol Lett 2012 0.79
99 Targeting autophagy for drug-induced hepatotoxicity. Autophagy 2012 0.79
100 Gender-specific reduction of hepatic Mrp2 expression by high-fat diet protects female mice from ANIT toxicity. Toxicol Appl Pharmacol 2012 0.79
101 Pathophysiological relevance of proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol Sci 2011 0.78
102 Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action. ALTEX 2014 0.78
103 Comments on "glycogen synthase kinase-3 mediates acetaminophen-induced apoptosis in human hepatoma cells". J Pharmacol Exp Ther 2005 0.77
104 Apoptosis or necrosis in acetaminophen-induced acute liver failure? New insights from mechanistic biomarkers*. Crit Care Med 2013 0.77
105 The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury. Xenobiotica 2014 0.77
106 Xanthine oxidase-induced oxidant stress during hepatic ischemia-reperfusion: are we coming full circle after 20 years? Hepatology 2002 0.77
107 Hepatitis C virus structural proteins can exacerbate or ameliorate acetaminophen-induced liver injury in mice. Arch Toxicol 2015 0.77
108 Autophagy and acetaminophen hepatotoxicity: how useful are Atg7-deficient mice? J Gastroenterol 2012 0.77
109 Heme oxygenase-1 and platelets in hepatic ischemia reperfusion injury. J Gastroenterol Hepatol 2013 0.76
110 Critical role of CXC chemokines in endotoxemic liver injury in mice. J Leukoc Biol 2004 0.76
111 Comment on "Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury". J Immunol 2011 0.76
112 Reactive nitrogen species in acetaminophen-induced mitochondrial damage and toxicity in mouse hepatocytes: a cautionary note on the impact of cell culture conditions. Chem Res Toxicol 2010 0.75
113 DAMPen danger signals: novel therapeutic strategies against postischemic inflammation. Crit Care Med 2010 0.75
114 Therapeutic strategies against ischemia-reperfusion injury: stem cell therapy and beyond. Crit Care Med 2012 0.75
115 Involvement of Kupffer cells in the interaction between neutrophils and sinusoidal endothelial cells in rats. Shock 18(2):152-157, 2002. Shock 2003 0.75
116 Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro. Methods Mol Biol 2015 0.75
117 Sterile inflammation in acute liver injury: myth or mystery? Expert Rev Gastroenterol Hepatol 2015 0.75
118 15th International Symposium on Cells of the Hepatic Sinusoid, 2010. Liver Int 2011 0.75
119 Gene array analysis of the hepatic response to endotoxin in glutathione peroxidase-deficient mice. Toxicol Lett 2003 0.75
120 Redox considerations in hepatic injury and inflammation. Antioxid Redox Signal 2002 0.75
121 The Challenge of Drug-Induced Liver Injury (DILI) / Challenges and Management of Liver Cirrhosis. Preface. Dig Dis 2015 0.75